Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 86

1.

Method comparison for N-glycan profiling: Towards the standardization of glycoanalytical technologies for cell line analysis.

Kotsias M, Blanas A, van Vliet SJ, Pirro M, Spencer DIR, Kozak RP.

PLoS One. 2019 Oct 7;14(10):e0223270. doi: 10.1371/journal.pone.0223270. eCollection 2019.

2.

The Plasticity of the Carbohydrate Recognition Domain Dictates the Exquisite Mechanism of Binding of Human Macrophage Galactose-Type Lectin.

Diniz A, Coelho H, Dias JS, van Vliet SJ, Jiménez-Barbero J, Corzana F, Cabrita EJ, Marcelo F.

Chemistry. 2019 Aug 12. doi: 10.1002/chem.201902780. [Epub ahead of print]

PMID:
31404475
3.

Macrophage galactose-type lectin (MGL) is induced on M2 microglia and participates in the resolution phase of autoimmune neuroinflammation.

Ilarregui JM, Kooij G, Rodríguez E, van der Pol SMA, Koning N, Kalay H, van der Horst JC, van Vliet SJ, García-Vallejo JJ, de Vries HE, van Kooyk Y.

J Neuroinflammation. 2019 Jun 27;16(1):130. doi: 10.1186/s12974-019-1522-4.

4.

MGL Ligand Expression Is Correlated to Lower Survival and Distant Metastasis in Cervical Squamous Cell and Adenosquamous Carcinoma.

Sahasrabudhe NM, van der Horst JC, Spaans V, Kenter G, de Kroon C, Bosse T, van Vliet SJ, Jordanova ES.

Front Oncol. 2019 Jan 29;9:29. doi: 10.3389/fonc.2019.00029. eCollection 2019.

5.

Glycoproteomic Analysis of MGL-Binding Proteins on Acute T-Cell Leukemia Cells.

Pirro M, Schoof E, van Vliet SJ, Rombouts Y, Stella A, de Ru A, Mohammed Y, Wuhrer M, van Veelen PA, Hensbergen PJ.

J Proteome Res. 2019 Mar 1;18(3):1125-1132. doi: 10.1021/acs.jproteome.8b00796. Epub 2019 Jan 9.

6.

Disruption of sialic acid metabolism drives tumor growth by augmenting CD8+ T cell apoptosis.

Cornelissen LAM, Blanas A, van der Horst JC, Kruijssen L, Zaal A, O'Toole T, Wiercx L, van Kooyk Y, van Vliet SJ.

Int J Cancer. 2019 May 1;144(9):2290-2302. doi: 10.1002/ijc.32084. Epub 2019 Jan 3.

7.

Identification of a secondary binding site in human macrophage galactose-type lectin by microarray studies: Implications for the molecular recognition of its ligands.

Marcelo F, Supekar N, Corzana F, van der Horst JC, Vuist IM, Live D, Boons GPH, Smith DF, van Vliet SJ.

J Biol Chem. 2019 Jan 25;294(4):1300-1311. doi: 10.1074/jbc.RA118.004957. Epub 2018 Nov 30.

PMID:
30504228
8.

Transcriptional activation of fucosyltransferase (FUT) genes using the CRISPR-dCas9-VPR technology reveals potent N-glycome alterations in colorectal cancer cells.

Blanas A, Cornelissen LAM, Kotsias M, van der Horst JC, van de Vrugt HJ, Kalay H, Spencer DIR, Kozak RP, van Vliet SJ.

Glycobiology. 2019 Feb 1;29(2):137-150. doi: 10.1093/glycob/cwy096.

9.

Toll-Like Receptor 4 Triggering Promotes Cytosolic Routing of DC-SIGN-Targeted Antigens for Presentation on MHC Class I.

Horrevorts SK, Duinkerken S, Bloem K, Secades P, Kalay H, Musters RJ, van Vliet SJ, García-Vallejo JJ, van Kooyk Y.

Front Immunol. 2018 Jun 14;9:1231. doi: 10.3389/fimmu.2018.01231. eCollection 2018.

10.

Oncogenic BRAFV600E drives expression of MGL ligands in the colorectal cancer cell line HT29 through N-acetylgalactosamine-transferase 3.

Sahasrabudhe NM, Lenos K, van der Horst JC, Rodríguez E, van Vliet SJ.

Biol Chem. 2018 Jun 27;399(7):649-659. doi: 10.1515/hsz-2018-0120.

PMID:
29894293
11.

Corrigendum: Fucosylated Antigens in Cancer: An Alliance Toward Tumor Progression, Metastasis, and Resistance to Chemotherapy.

Blanas A, Sahasrabudhe NM, Rodríguez E, van Kooyk Y, van Vliet SJ.

Front Oncol. 2018 May 11;8:150. doi: 10.3389/fonc.2018.00150. eCollection 2018.

12.

Fucosylated Antigens in Cancer: An Alliance toward Tumor Progression, Metastasis, and Resistance to Chemotherapy.

Blanas A, Sahasrabudhe NM, Rodríguez E, van Kooyk Y, van Vliet SJ.

Front Oncol. 2018 Feb 23;8:39. doi: 10.3389/fonc.2018.00039. eCollection 2018. Review. Erratum in: Front Oncol. 2018 May 11;8:150.

13.

Using the glycan toolbox for pathogenic interventions and glycan immunotherapy.

Li RE, van Vliet SJ, van Kooyk Y.

Curr Opin Biotechnol. 2018 Jun;51:24-31. doi: 10.1016/j.copbio.2017.11.003. Epub 2017 Nov 22. Review.

PMID:
29175707
14.

Effectiveness of three commonly used transition phase diets in the inpatient management of children with severe acute malnutrition: a pilot randomized controlled trial in Malawi.

Versloot CJ, Voskuijl W, van Vliet SJ, van den Heuvel M, Carter JC, Phiri A, Kerac M, Heikens GT, van Rheenen PF, Bandsma RHJ.

BMC Pediatr. 2017 Apr 26;17(1):112. doi: 10.1186/s12887-017-0860-6.

15.

Mortality in children with complicated severe acute malnutrition is related to intestinal and systemic inflammation: an observational cohort study.

Attia S, Versloot CJ, Voskuijl W, van Vliet SJ, Di Giovanni V, Zhang L, Richardson S, Bourdon C, Netea MG, Berkley JA, van Rheenen PF, Bandsma RH.

Am J Clin Nutr. 2016 Nov;104(5):1441-1449. Epub 2016 Sep 21.

16.

Blocking α1-integrin reverts the adhesive phenotype of adult fibroblasts towards a foetal-like migratory phenotype.

Walraven M, van Vliet SJ, Beelen RH, van Egmond M, Ulrich MM.

Exp Dermatol. 2016 Jun;25(6):480-2. doi: 10.1111/exd.12977. Epub 2016 May 6. No abstract available.

PMID:
27294728
17.

Sialic acid removal from dendritic cells improves antigen cross-presentation and boosts anti-tumor immune responses.

Silva M, Silva Z, Marques G, Ferro T, Gonçalves M, Monteiro M, van Vliet SJ, Mohr E, Lino AC, Fernandes AR, Lima FA, van Kooyk Y, Matos T, Tadokoro CE, Videira PA.

Oncotarget. 2016 Jul 5;7(27):41053-41066. doi: 10.18632/oncotarget.9419.

18.

A Bitter Sweet Symphony: Immune Responses to Altered O-glycan Epitopes in Cancer.

Cornelissen LA, Van Vliet SJ.

Biomolecules. 2016 May 3;6(2). pii: E26. doi: 10.3390/biom6020026. Review.

19.

The Human Glycoprotein Salivary Agglutinin Inhibits the Interaction of DC-SIGN and Langerin with Oral Micro-Organisms.

Boks MA, Gunput ST, Kosten I, Gibbs S, van Vliet SJ, Ligtenberg AJ, van Kooyk Y.

J Innate Immun. 2016;8(4):350-61. doi: 10.1159/000443016. Epub 2016 Apr 16.

20.

Apoptotic vesicles as tumor vaccine.

Horrevorts SK, Garcia-Vallejo JJ, van Vliet SJ, van de Loosdrecht AA, van Kooyk Y, de Gruijl TD.

Immunotherapy. 2016;8(1):5-8. doi: 10.2217/imt.15.96. Epub 2015 Dec 7. No abstract available.

PMID:
26641072
21.

N-glycosylation Profiling of Colorectal Cancer Cell Lines Reveals Association of Fucosylation with Differentiation and Caudal Type Homebox 1 (CDX1)/Villin mRNA Expression.

Holst S, Deuss AJ, van Pelt GW, van Vliet SJ, Garcia-Vallejo JJ, Koeleman CA, Deelder AM, Mesker WE, Tollenaar RA, Rombouts Y, Wuhrer M.

Mol Cell Proteomics. 2016 Jan;15(1):124-40. doi: 10.1074/mcp.M115.051235. Epub 2015 Nov 4.

22.

Langerin-mediated internalization of a modified peptide routes antigens to early endosomes and enhances cross-presentation by human Langerhans cells.

Fehres CM, Duinkerken S, Bruijns SC, Kalay H, van Vliet SJ, Ambrosini M, de Gruijl TD, Unger WW, Garcia-Vallejo JJ, van Kooyk Y.

Cell Mol Immunol. 2017 Apr;14(4):360-370. doi: 10.1038/cmi.2015.87. Epub 2015 Oct 12.

23.

IFN-β affects the angiogenic potential of circulating angiogenic cells by activating calpain 1.

Yıldırım C, Favre J, Weijers EM, Fontijn RD, van Wijhe MH, van Vliet SJ, Boon RA, Koolwijk P, van der Pouw Kraan TC, Horrevoets AJ.

Am J Physiol Heart Circ Physiol. 2015 Nov 15;309(10):H1667-78. doi: 10.1152/ajpheart.00810.2014. Epub 2015 Oct 2.

24.

Hypoxia inducible factor 1α down regulates cell surface expression of α1,2-fucosylated glycans in human pancreatic adenocarcinoma cells.

Belo AI, van Vliet SJ, Maus A, Laan LC, Nauta TD, Koolwijk P, Tefsen B, van Die I.

FEBS Lett. 2015 Aug 19;589(18):2359-66. doi: 10.1016/j.febslet.2015.07.035. Epub 2015 Jul 29.

25.

Trichuris suis induces human non-classical patrolling monocytes via the mannose receptor and PKC: implications for multiple sclerosis.

Kooij G, Braster R, Koning JJ, Laan LC, van Vliet SJ, Los T, Eveleens AM, van der Pol SM, Förster-Waldl E, Boztug K, Belot A, Szilagyi K, van den Berg TK, van Buul JD, van Egmond M, de Vries HE, Cummings RD, Dijkstra CD, van Die I.

Acta Neuropathol Commun. 2015 Jul 25;3:45. doi: 10.1186/s40478-015-0223-1.

26.

MGL ligand expression is correlated to BRAF mutation and associated with poor survival of stage III colon cancer patients.

Lenos K, Goos JA, Vuist IM, den Uil SH, Delis-van Diemen PM, Belt EJ, Stockmann HB, Bril H, de Wit M, Carvalho B, Giblett S, Pritchard CA, Meijer GA, van Kooyk Y, Fijneman RJ, van Vliet SJ.

Oncotarget. 2015 Sep 22;6(28):26278-90. doi: 10.18632/oncotarget.4495.

27.

The Cholangiocyte Glycocalyx Stabilizes the 'Biliary HCO3 Umbrella': An Integrated Line of Defense against Toxic Bile Acids.

Maillette de Buy Wenniger LJ, Hohenester S, Maroni L, van Vliet SJ, Oude Elferink RP, Beuers U.

Dig Dis. 2015;33(3):397-407. doi: 10.1159/000371864. Epub 2015 May 27. Review.

PMID:
26045275
28.

The Consequences of Multiple Simultaneous C-Type Lectin-Ligand Interactions: DCIR Alters the Endo-Lysosomal Routing of DC-SIGN.

García-Vallejo JJ, Bloem K, Knippels LM, Garssen J, van Vliet SJ, van Kooyk Y.

Front Immunol. 2015 Mar 10;6:87. doi: 10.3389/fimmu.2015.00087. eCollection 2015.

29.

Cross-presentation through langerin and DC-SIGN targeting requires different formulations of glycan-modified antigens.

Fehres CM, Kalay H, Bruijns SC, Musaafir SA, Ambrosini M, van Bloois L, van Vliet SJ, Storm G, Garcia-Vallejo JJ, van Kooyk Y.

J Control Release. 2015 Apr 10;203:67-76. doi: 10.1016/j.jconrel.2015.01.040. Epub 2015 Feb 2.

PMID:
25656175
30.

Antibody-opsonized bacteria evoke an inflammatory dendritic cell phenotype and polyfunctional Th cells by cross-talk between TLRs and FcRs.

Bakema JE, Tuk CW, van Vliet SJ, Bruijns SC, Vos JB, Letsiou S, Dijkstra CD, van Kooyk Y, Brenkman AB, van Egmond M.

J Immunol. 2015 Feb 15;194(4):1856-66. doi: 10.4049/jimmunol.1303126. Epub 2015 Jan 12.

31.

Novel insights into the immunomodulatory role of the dendritic cell and macrophage-expressed C-type lectin MGL.

van Kooyk Y, Ilarregui JM, van Vliet SJ.

Immunobiology. 2015 Feb;220(2):185-92. doi: 10.1016/j.imbio.2014.10.002. Epub 2014 Oct 14. Review.

PMID:
25454488
32.

P-glycoprotein regulates trafficking of CD8(+) T cells to the brain parenchyma.

Kooij G, Kroon J, Paul D, Reijerkerk A, Geerts D, van der Pol SM, van Het Hof B, Drexhage JA, van Vliet SJ, Hekking LH, van Buul JD, Pachter JS, de Vries HE.

Acta Neuropathol. 2014 May;127(5):699-711. doi: 10.1007/s00401-014-1244-8. Epub 2014 Jan 16.

PMID:
24429546
33.

DCIR interacts with ligands from both endogenous and pathogenic origin.

Bloem K, Vuist IM, van den Berk M, Klaver EJ, van Die I, Knippels LM, Garssen J, García-Vallejo JJ, van Vliet SJ, van Kooyk Y.

Immunol Lett. 2014 Mar-Apr;158(1-2):33-41. doi: 10.1016/j.imlet.2013.11.007. Epub 2013 Nov 14.

PMID:
24239607
34.

Human T cell activation results in extracellular signal-regulated kinase (ERK)-calcineurin-dependent exposure of Tn antigen on the cell surface and binding of the macrophage galactose-type lectin (MGL).

van Vliet SJ, Vuist IM, Lenos K, Tefsen B, Kalay H, García-Vallejo JJ, van Kooyk Y.

J Biol Chem. 2013 Sep 20;288(38):27519-32. doi: 10.1074/jbc.M113.471045. Epub 2013 Aug 5.

35.

Ligand binding and signaling of dendritic cell immunoreceptor (DCIR) is modulated by the glycosylation of the carbohydrate recognition domain.

Bloem K, Vuist IM, van der Plas AJ, Knippels LM, Garssen J, García-Vallejo JJ, van Vliet SJ, van Kooyk Y.

PLoS One. 2013 Jun 11;8(6):e66266. doi: 10.1371/journal.pone.0066266. Print 2013.

36.

MGL signaling augments TLR2-mediated responses for enhanced IL-10 and TNF-α secretion.

van Vliet SJ, Bay S, Vuist IM, Kalay H, García-Vallejo JJ, Leclerc C, van Kooyk Y.

J Leukoc Biol. 2013 Aug;94(2):315-23. doi: 10.1189/jlb.1012520. Epub 2013 Jun 6.

PMID:
23744646
37.

Interaction of the Capsular Polysaccharide A from Bacteroides fragilis with DC-SIGN on Human Dendritic Cells is Necessary for Its Processing and Presentation to T Cells.

Bloem K, García-Vallejo JJ, Vuist IM, Cobb BA, van Vliet SJ, van Kooyk Y.

Front Immunol. 2013 May 6;4:103. doi: 10.3389/fimmu.2013.00103. eCollection 2013.

38.

Trichuris suis-induced modulation of human dendritic cell function is glycan-mediated.

Klaver EJ, Kuijk LM, Laan LC, Kringel H, van Vliet SJ, Bouma G, Cummings RD, Kraal G, van Die I.

Int J Parasitol. 2013 Mar;43(3-4):191-200. doi: 10.1016/j.ijpara.2012.10.021. Epub 2012 Dec 7.

PMID:
23220043
39.

Specific glycan elements determine differential binding of individual egg glycoproteins of the human parasite Schistosoma mansoni by host C-type lectin receptors.

Meevissen MH, Driessen NN, Smits HH, Versteegh R, van Vliet SJ, van Kooyk Y, Schramm G, Deelder AM, Haas H, Yazdanbakhsh M, Hokke CH.

Int J Parasitol. 2012;42(3):269-77.

PMID:
22673410
40.

Galactosaminogalactan, a new immunosuppressive polysaccharide of Aspergillus fumigatus.

Fontaine T, Delangle A, Simenel C, Coddeville B, van Vliet SJ, van Kooyk Y, Bozza S, Moretti S, Schwarz F, Trichot C, Aebi M, Delepierre M, Elbim C, Romani L, Latgé JP.

PLoS Pathog. 2011 Nov;7(11):e1002372. doi: 10.1371/journal.ppat.1002372. Epub 2011 Nov 10.

41.

A biliary HCO3- umbrella constitutes a protective mechanism against bile acid-induced injury in human cholangiocytes.

Hohenester S, Wenniger LM, Paulusma CC, van Vliet SJ, Jefferson DM, Elferink RP, Beuers U.

Hepatology. 2012 Jan;55(1):173-83. doi: 10.1002/hep.24691.

PMID:
21932391
42.

T cell-mediated increased osteoclast formation from peripheral blood as a mechanism for Crohn's disease-associated bone loss.

Oostlander AE, Everts V, Schoenmaker T, Bravenboer N, van Vliet SJ, van Bodegraven AA, Lips P, de Vries TJ.

J Cell Biochem. 2012 Jan;113(1):260-8. doi: 10.1002/jcb.23352.

PMID:
21898548
43.

Campylobacter jejuni lipooligosaccharides modulate dendritic cell-mediated T cell polarization in a sialic acid linkage-dependent manner.

Bax M, Kuijf ML, Heikema AP, van Rijs W, Bruijns SC, García-Vallejo JJ, Crocker PR, Jacobs BC, van Vliet SJ, van Kooyk Y.

Infect Immun. 2011 Jul;79(7):2681-9. doi: 10.1128/IAI.00009-11. Epub 2011 Apr 18.

44.

Variation of Neisseria gonorrhoeae lipooligosaccharide directs dendritic cell-induced T helper responses.

van Vliet SJ, Steeghs L, Bruijns SC, Vaezirad MM, Snijders Blok C, Arenas Busto JA, Deken M, van Putten JP, van Kooyk Y.

PLoS Pathog. 2009 Oct;5(10):e1000625. doi: 10.1371/journal.ppat.1000625. Epub 2009 Oct 16.

45.

Interaction of polysialic acid with CCL21 regulates the migratory capacity of human dendritic cells.

Bax M, van Vliet SJ, Litjens M, García-Vallejo JJ, van Kooyk Y.

PLoS One. 2009 Sep 14;4(9):e6987. doi: 10.1371/journal.pone.0006987.

46.

N-glycosylated proteins and distinct lipooligosaccharide glycoforms of Campylobacter jejuni target the human C-type lectin receptor MGL.

van Sorge NM, Bleumink NM, van Vliet SJ, Saeland E, van der Pol WL, van Kooyk Y, van Putten JP.

Cell Microbiol. 2009 Dec;11(12):1768-81. doi: 10.1111/j.1462-5822.2009.01370.x. Epub 2009 Aug 13.

PMID:
19681908
47.

Characterization of murine MGL1 and MGL2 C-type lectins: distinct glycan specificities and tumor binding properties.

Singh SK, Streng-Ouwehand I, Litjens M, Weelij DR, García-Vallejo JJ, van Vliet SJ, Saeland E, van Kooyk Y.

Mol Immunol. 2009 Mar;46(6):1240-9. doi: 10.1016/j.molimm.2008.11.021. Epub 2009 Jan 21.

PMID:
19162326
48.

The C-type lectin macrophage galactose-type lectin impedes migration of immature APCs.

van Vliet SJ, Paessens LC, Broks-van den Berg VC, Geijtenbeek TB, van Kooyk Y.

J Immunol. 2008 Sep 1;181(5):3148-55.

49.

Dendritic cells and C-type lectin receptors: coupling innate to adaptive immune responses.

van Vliet SJ, García-Vallejo JJ, van Kooyk Y.

Immunol Cell Biol. 2008 Oct;86(7):580-7. doi: 10.1038/icb.2008.55. Epub 2008 Aug 5. Review.

PMID:
18679407
50.

Sweet preferences of MGL: carbohydrate specificity and function.

van Vliet SJ, Saeland E, van Kooyk Y.

Trends Immunol. 2008 Feb;29(2):83-90. doi: 10.1016/j.it.2007.10.010. Epub 2008 Jan 14. Review.

PMID:
18249034

Supplemental Content

Loading ...
Support Center